Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology

Leukemia

Volumn 10, Issue 4, 1996, Pages 662-668

  Bernell, P ^a   Jacobsson, B ^a   Nordgren, A ^b   Hast, R ^a  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute myeloid leukemia; Bone marrow; Cytogenetics; Fluorescence in situ hybridization; Morphology; Myelodysplastic syndromes

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BLAST CELL; BONE MARROW CELL; CELL LINEAGE; CELL STRUCTURE; CELL TRANSFORMATION; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA PROBE; ERYTHROCYTE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GRANULOCYTE; HUMAN; HUMAN CELL; LYMPHOCYTE; LYMPHOCYTE CLONE; MALE; MONOCYTE; MONOSOMY 7; MYELODYSPLASTIC SYNDROME; PLASMA CELL; PRIORITY JOURNAL; PROGNOSIS; TRISOMY 8;

EID: 0029965106     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Koeffler HP. Myelodysplastic syndromes (preleukemia). Clin Haematol 1986; 15: 829-850.
2. Pierre RV, Catovsky D, Mufti GJ, Swansbury GJ, Mecuci C, Dewald GW, Ruutu T, Van den Berghe H, Rowley JD, Mitelman F, Reeves BR, Alimena G, Garson OM, Lawler SD, De la Chapelle A. Clinical-cytogenetic correlations in myelodysplasia (preleukemia). Cancer Genet Cytogenet 1989, 40: 149-161.
3. Prchal JT, Trockmorton DW, Carroll AJ, Fuson EW, Gams RA, Prchal JF. A common progenitor for human myeloid and lymphoid cells. Nature 1978; 274: 590-591.
4. Cremer T, Lichter P, Borden J, Ward DC, Manuelidis L. Detection of chromosome abberations in metaphase and interphase tumor cells by in situ hybridization using chromosome-specific library probes. Hum Cenet 1988; 80: 235-246.
5. Anastasi J, Feng J, Le Beau MM, Larson RA, Rowley JD, Vardiman JW. Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: lineage, response to growth factor therapy, and clone expansion. Blood 1993; 81: 1580-1585.
6. Nylund SJ, Verbeek W, Larramendy ML, Ruutu T, Heinonen K, Hallman H, Knuutila S. Cell lineage involvement in four patients with myelodysplastic syndrome and t(1;7) or trisomy 8. Studied by simultaneous immunophenotyping and fluorescence in situ hybridization. Cancer Genet Cytogenet 1993; 70: 120-124.
7. Kibbelaar RE, van Kamp H, Dreef EJ, de Groot-Swings C, Kluin-Nelemans JC, Beverstock GC, Fibbe WE, Kluin PHM. Combined immunophenotyping and DNA in situ hybridization to study lineage involvement in patients with myelodysplastic syndromes. Blood 1992; 79: 1823-1828.
8. Gerritsen WR, Donohue J, Bauman J, Jhanwar SC, Kernan NA, Castro-Malaspian H, O'Reilly RJ, Bourhis JH. Clonal analysis of myelodyspiastic syndromes: monosomy 7 is expressed in the myeloid lineage, but not in the lymphoid lineage as detected by fluorescent in situ hybridization. Blood 1992; 80; 217-224.
9. van Lom K, Hagemeijer A, Smit EME, Lowenberg B. In situ hybridization on May-Grünwald Giemsa-stained bone marrow and blood smears of patients with hématologie disorders allow detection of cell-lineage-specific cytogenetic abnormalities. Blood 1993; 82: 884-888.
10. Jakobsson B, Bernell P, Arvidsson I, Hast R. Classical morphology, esterase cytochemistry and interphase cytogenetics of peripheral blood and bone marrow smears. J Histochem Cytochem (Submitted).
11. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C. Proposals for the classification of the myelodysplastic syndromes The French-American-British (FAB) Cooperative group. Br J Haematol 1982; 51: 189-199.
12. Colombat P, Binet C, Desbois I, Lamagnere JP. Les leucemias myelomonocytaires chroniques font partie du cadre des amemies refractaires. Plaidoyer a propos de treize observations. Semaine des Hopitaux Paris 1985; 61: 765-769.
13. Lintula R. Red cell enzymes in myelodysplastic syndromes: a review. Scand J Haematol 1986, 36 (Suppl. 45): 56-59.
14. van Lom K, Hagemeijer A, Smit EME, Lowenberg B. Cytogenetic clonality analysis in myelodyspiastic syndromes (MDS), de novo acute myeloid leukemia (AML) and AML post MDS. Br J Haematol 1994; 87: 548a.
15. Brito-Babapulle F, Catovsky D, Galton DAG. Clinical and laboratory features of de novo acute myeioid leukemia with trilineage myelodysplasi. Br J Haematol 1987; 66: 445-450.
16. Goasguen JE, Bennett JM. Classification and morphologic features of the myelodysplastic syndromes. Semin Oncol 1992; 19: 4-13.
17. ISCN (1991). Guidelines for Cancer Cytogenetics, Supplement to an International System for Human Cytogenetic Nomenclature. F Mitelman (ed). Karger: Basel, 1991.
18. Jenkins RB, Le Beau MM, Kraker WJ, Borell TJ, Stalboerger PG, Davis EM, Penland L, Fernald A, Espinosa III R, Schaid DJ, Noel P, Dewald GW. Fluorescence in situ hybridization: a sensitive method for trisomy 8 detection in bone marrow specimens. Blood 1992; 79: 3307-3315.
19. Kibbelaar RE, Mulder JWR, Dreef EJ, van Kamp H, Fibbe WE, Wessels JW, Beverstock GC, Haak HL, Kluin PH. Detection of monosomy 7 and trisomy 8 in myeloid neoplasia: a comparison of banding and fluorescence in situ hybridization. Blood 1993; 82: 904-913.